The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant

Abstract Many links between gut microbiota and disease development have been established in recent years, with particular bacterial strains emerging as potential therapeutics rather than causative agents. In this study we describe the immunostimulatory properties of Enterococcus gallinarum MRx0518,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Delphine L. Lauté-Caly, Emma J. Raftis, Philip Cowie, Emma Hennessy, Amy Holt, D. Alessio Panzica, Christina Sparre, Beverley Minter, Eline Stroobach, Imke E. Mulder
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a63f85fe141442f2bdca2dc83fc8d215
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a63f85fe141442f2bdca2dc83fc8d215
record_format dspace
spelling oai:doaj.org-article:a63f85fe141442f2bdca2dc83fc8d2152021-12-02T15:07:54ZThe flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant10.1038/s41598-018-36926-82045-2322https://doaj.org/article/a63f85fe141442f2bdca2dc83fc8d2152019-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-36926-8https://doaj.org/toc/2045-2322Abstract Many links between gut microbiota and disease development have been established in recent years, with particular bacterial strains emerging as potential therapeutics rather than causative agents. In this study we describe the immunostimulatory properties of Enterococcus gallinarum MRx0518, a candidate live biotherapeutic with proven anti-tumorigenic efficacy. Here we demonstrate that strain MRx0518 elicits a strong pro-inflammatory response in key components of the innate immune system but also in intestinal epithelial cells. Using a flagellin knock-out derivative and purified recombinant protein, MRx0518 flagellin was shown to be a TLR5 and NF-κB activator in reporter cells and an inducer of IL-8 production by HT29-MTX cells. E. gallinarum flagellin proteins display a high level of sequence diversity and the flagellin produced by MRx0518 was shown to be more potent than flagellin from E. gallinarum DSM100110. Collectively, these data infer that flagellin may play a role in the therapeutic properties of E. gallinarum MRx0518.Delphine L. Lauté-CalyEmma J. RaftisPhilip CowieEmma HennessyAmy HoltD. Alessio PanzicaChristina SparreBeverley MinterEline StroobachImke E. MulderNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Delphine L. Lauté-Caly
Emma J. Raftis
Philip Cowie
Emma Hennessy
Amy Holt
D. Alessio Panzica
Christina Sparre
Beverley Minter
Eline Stroobach
Imke E. Mulder
The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
description Abstract Many links between gut microbiota and disease development have been established in recent years, with particular bacterial strains emerging as potential therapeutics rather than causative agents. In this study we describe the immunostimulatory properties of Enterococcus gallinarum MRx0518, a candidate live biotherapeutic with proven anti-tumorigenic efficacy. Here we demonstrate that strain MRx0518 elicits a strong pro-inflammatory response in key components of the innate immune system but also in intestinal epithelial cells. Using a flagellin knock-out derivative and purified recombinant protein, MRx0518 flagellin was shown to be a TLR5 and NF-κB activator in reporter cells and an inducer of IL-8 production by HT29-MTX cells. E. gallinarum flagellin proteins display a high level of sequence diversity and the flagellin produced by MRx0518 was shown to be more potent than flagellin from E. gallinarum DSM100110. Collectively, these data infer that flagellin may play a role in the therapeutic properties of E. gallinarum MRx0518.
format article
author Delphine L. Lauté-Caly
Emma J. Raftis
Philip Cowie
Emma Hennessy
Amy Holt
D. Alessio Panzica
Christina Sparre
Beverley Minter
Eline Stroobach
Imke E. Mulder
author_facet Delphine L. Lauté-Caly
Emma J. Raftis
Philip Cowie
Emma Hennessy
Amy Holt
D. Alessio Panzica
Christina Sparre
Beverley Minter
Eline Stroobach
Imke E. Mulder
author_sort Delphine L. Lauté-Caly
title The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
title_short The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
title_full The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
title_fullStr The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
title_full_unstemmed The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
title_sort flagellin of candidate live biotherapeutic enterococcus gallinarum mrx0518 is a potent immunostimulant
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/a63f85fe141442f2bdca2dc83fc8d215
work_keys_str_mv AT delphinellautecaly theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT emmajraftis theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT philipcowie theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT emmahennessy theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT amyholt theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT dalessiopanzica theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT christinasparre theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT beverleyminter theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT elinestroobach theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT imkeemulder theflagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT delphinellautecaly flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT emmajraftis flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT philipcowie flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT emmahennessy flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT amyholt flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT dalessiopanzica flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT christinasparre flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT beverleyminter flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT elinestroobach flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
AT imkeemulder flagellinofcandidatelivebiotherapeuticenterococcusgallinarummrx0518isapotentimmunostimulant
_version_ 1718388337311481856